Kodiak director granted options for 17,731 shares
Kodiak Sciences director Charles A. Bancroft received a new stock option grant, giving him the right to buy 17,731 shares of common stock at an exercise price of $38.96 per share.
Rhea-AI Filing Summary
Kodiak Sciences director Charles A. Bancroft received a new stock option grant, giving him the right to buy 17,731 shares of common stock at an exercise price of $38.96 per share. These options were granted at no cost to him on June 30, 2026.
The entire option grant vests in a single tranche on the earlier of June 30, 2027 or one day before Kodiak Sciences’ next annual shareholder meeting after the grant date, as long as Bancroft continues to serve on the company’s board of directors through that vesting date. After this grant, he holds options for 17,731 shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 17,731 shares
Grant/Award
1 txn
Insider
Bancroft Charles A
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 17,731 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 17,731 contracts (Direct)
Footnotes (1)
- F1. One hundred percent (100%) of the shares subject to the option shall vest upon the earlier of June 30, 2027 or one (1) day prior to the Issuer's next annual meeting occurring after the grant date, in each case, provided the Reporting Person continues to serve as a member of the Issuer's board of directors through the applicable vesting date.
Key Figures
Option shares granted: 17,731 shares
Exercise price: $38.96 per share
Shares underlying options: 17,731 shares
+3 more
6 metrics
Option shares granted
17,731 shares
Stock Option (Right to Buy) grant on June 30, 2026
Exercise price
$38.96 per share
Strike price for the 17,731 option shares
Shares underlying options
17,731 shares
Common stock underlying the new option award
Post-grant option holdings
17,731 options
Total derivative shares following the reported transaction
Option expiration date
June 29, 2036
Final date to exercise the granted options
Cliff vesting date
June 30, 2027
Latest vesting trigger if earlier annual meeting date does not apply
Key Terms
Stock Option (Right to Buy), exercise price, vest, board of directors
4 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
exercise price financial
"conversion_or_exercise_price: "38.9600""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest financial
"One hundred percent (100%) of the shares subject to the option shall vest upon the earlier of June 30, 2027..."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
board of directors financial
"provided the Reporting Person continues to serve as a member of the Issuer's board of directors through the applicable vesting date"
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Kodiak Sciences (KOD) director Charles Bancroft report on this Form 4?
Charles A. Bancroft reported receiving a stock option grant for 17,731 shares of Kodiak Sciences common stock. The options are a compensation award and not an open-market purchase, reflecting a new right to buy shares rather than an immediate cash transaction or sale.
What is the exercise price of Charles Bancroft’s Kodiak Sciences stock options?
The options have an exercise price of $38.96 per share. This means Bancroft can purchase Kodiak Sciences common stock at $38.96 for each share covered by the option if he exercises after the options have vested and before they expire.
When do Charles Bancroft’s Kodiak Sciences options vest?
One hundred percent of the option shares vest on the earlier of June 30, 2027 or one day before Kodiak Sciences’ next annual meeting after the grant date. Vesting requires that Bancroft continue serving on the board through the applicable vesting date.
When do the newly granted Kodiak Sciences stock options expire?
The options expire on June 29, 2036. After that expiration date, Bancroft can no longer exercise the options to buy Kodiak Sciences shares, even if they have vested and were previously exercisable during the option term.
Is this Kodiak Sciences (KOD) Form 4 a stock purchase or a compensation award?
This filing reflects a compensation-related award, not an open-market purchase. Bancroft received stock options at no cost, giving him the right to buy shares later. The transaction is classified as a grant or award acquisition under code A, a routine director compensation mechanism.
AI-generated analysis. How Rhea-AI works. Not financial advice.
